Estimation of bilastine and montelukast by stability indicating liquid chromatographic method in pure binary mixture and their marketed tablets
Keywords:
Bilastine, Montelukast Stability indicating, C18 column, Isocratic elutionAbstract
The main objective of the current work is to develop and validate a new RP-HPLC method for estimation of Bilastine and Montelukast in bulk and in their combined tablets. A good separation of both analytes in various types solutions was attained by using a Ascentis C18 (150 x 4.6mm, 2.6µ) column with a solvent or mobile phase of 0.1% OPA: acetonitrile (50:50 v/v) at a flow rate of 1ml/min and a detection wavelength of 230nm. To test the stability of the analytes, the drug substance was put in an environment with a lot of stress, such as hydrolysis with acid and base, peroxide oxidation, and thermal degradation. At at 2.25min and 2.78 min, Bilastine and Montelukast were eluted with isocratic elution. The method is expected to show a linear response from 2.5 to 15µg/ml for Bilastine and from 5 to 30 µg/ml for Montelukast. Bilastine's LOD and LOQ were establishe to be 0.1and 0.31µg/ml, while Montelukast's were 0.3 and 0.91µg/ml. From the Bilastine and Montelukast peaks, the degradant peaks that were made were easy to tell apart. The method was very sensitive, accurate, cost-effective, and showed stability.
Downloads
References
Andhale SM, Nikalje APG. Simultaneous Estimation of Bilastine and Montelukast in Bulk by Rp-hplc and Assessment of Its Applicability in Marketed Tablet Dosage Form. JPRI. 2022;34(3B):8-25.
Baig S, Khan RA, Khan K, Rizvi N. Effectiveness and quality of life with montelukast in asthma- A double-blind, randomized control trial. Pak J Med Sci. 2019;35(3):731-36.
Chandra U, Kumar M, Sharma S, Gupta P. Development and validation of RP-HPLC method for In-Vitro Dissolution Testing of Bilastine and Montelukast Sodium Tablets. Int. J. Pharm. Sci. Drug Res. 2021;13(3):281-7
Corcóstegui R, Labeaga L, Innerárity A, Berisa A, Orjales A. In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist. Drugs R D. 2006;7(4):219-31.
Corcóstegui R, Labeaga L, Innerarity A, Berisa A, Orjales A. Preclinical pharmacology of bilastine, a new selective histamine H 1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity. Drugs R D. 2005;6(6):371-84.
Djuraev, A. M., Alpisbaev, K. S., & Tapilov, E. A. (2021). The choice of surgical tactics for the treatment of children with destructive pathological dislocation of the hip after hematogenous osteomyelitis. International Journal of Health & Medical Sciences, 5(1), 15-20. https://doi.org/10.21744/ijhms.v5n1.1813
Gholve S, Thonte S, Bhusnure O. RP-HPLC method development and validation of montelukast sodium in bulk drug and dosage form. Int J Pharm Bio Sci. 2015;6(2): 354 – 360..
Hon KL, Leung TF, Leung AK. Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses? Drug Des Dev Ther. 2014;8:839-50.
International Conference on Harmonization (ICH). Harmonized tripartite guideline validation of analytical procedures: text and methodology Q2. Vol. R1. Switzerland; 2005.
International Conference on Harmonization (ICH). Stability testing of new drug substances and products Q1A. Vol. R2. Geneva, Switzerland; 2003.
Lavorini F, Matucci A, Rossi O, Pistolesi M; SKY study investigators. Concomitant bilastine and montelukast as additive therapy for seasonal allergic rhinoconjunctivits and mild-to-moderate asthma. The SKY study. Allergy. 2020;75(3):675-677.
Paggiaro P, Bacci E. Montelukast in asthma: a review of its efficacy and place in therapy. Ther Adv Chronic Dis. 2011;2(1):47-58.
Paggiaro P, Bacci E. Montelukast in asthma: a review of its efficacy and place in therapy. Ther Adv Chronic Dis. 2011;2(1):47-58.
Pardeshi PP, Gaware VM, Dhamak KB, Development and Validation of RP-HPLC Method for the Estimation of Bilastine from bulk and Formulation. Asian J. Pharm. Ana. 2020;10(2): 109-111.
Patel KK, Patel AM, Patel CN. A new simple RP-HPLC Method development, Validation and Forced degradation studies of Bilastine. Asian J. Pharm. Ana. 2021;11(3):183-7.
Patel P, Panchal ZA, Patel S, Patel D. In depth investigation of analytical methods for the determination of montelukast and bilastine in biological fluid and pharmaceutical dosage forms: A Review. Research J. Pharm. and Tech.2020;14(12):6761-7.
Raj RM, Sankar ASK, Vetrichelvan T. Analytical method development and validation for simultaneous estimation of bilastine and montelukast sodium by UV spectrophotometry. World J Pharm Pharm Sci. 2020;10:680-7
Rana NS, Rajesh KS, Patel NN, Patel PR, Limbachiya U, Pasha TY. Development and Validation of RP‑HPLC Method for the Simultaneous Estimation of Montelukast Sodium and Ebastine in Tablet Dosage Form. Indian J Pharm Sci. 2013:75(5): 599-602
Ridolo E, Montagni M, Bonzano L, Incorvaia C, Canonica GW. Bilastine: new insight into antihistamine treatment. Clin Mol Allergy. 2015;13(1):1.
Shinde A, Gajeli GB, Ubale S, Matole V. Simultaneous HPLC method development and validation of bilastine and montelukast in bulk and formulation. Research J. Pharm. and Tech. 2021;14(11):6061-5.
Singh RM, Saini PK, Mathur SC, Singh GN, Lal B. Development and Validation of an RP-HPLC Method for Estimation of Montelukast Sodium in Bulk and Tablet Dosage Form. Indian J Pharm Sci.: 2010;72(2): 235-237.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Vairagi KP, Desai SP. A review on analytical method development for simultaneous estimation and validation of Montelukast Sodium and Bilastine. World Journal of Pharmaceutical Research. 2021;10(4):665-78.
Vijayalakshmi K, Anand B, Nageswara B. Quantification of Bilastine and Montelukast Combination in Formulations Utilizing Liquid Chromatography: Stability Studies. Int J App Pharm . 2021;13(6):210-5.
Vyas P, Thakur VS, Basedia D, Dubey B. Development and Validation of RP-HPLC based Analytical method for Simultaneous Estimation of Montelukast and Bilastine in Tablet Dosage Form. Current Research in Pharmaceutical Sciences. 2022 Apr 6:68-73.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
